Accessibility and equity considerations in the clinical validation of prescription digital therapeutics: a scoping review

Key Points

• Clinical validation lacks thorough assessments of health equity, raising concerns for equitable healthcare access.
• The review emphasizes the need for improved cultural competence in the development of digital therapeutics to reach diverse populations.
• Digital accessibility remains a significant gap, suggesting that some populations may be overlooked in therapeutic effectiveness assessments.
• Addressing these gaps is essential for ensuring that digital therapeutics are both accessible and effective across varying demographics.

Abstract